Seasonal Influenza and Pneumococcal Vaccination in the Elderly

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1166 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-15

Study Completion Date

2023-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The elderly population and individuals with chronic diseases are at high risk for influenza and influenza-related pneumonia, and it is emphasized that taking pneumonia and influenza vaccine together is effective in reducing mortality as well as hospitalization rates and costs due to pneumonia, influenza, and congestive heart disease.

This study that will be carried out will enable to determine the population-based prevalence of the relevant vaccines in the elderly and to determine the determinants of vaccination with the case group to be determined based on this.

The aim of the study is two phases.

1. Determination of the prevalence of seasonal influenza and pneumococcal vaccination in elderly people over the over the age of 65 living in Ankara.
2. Investigation of socioeconomic characteristics and vaccine indecision and some health-related determinants of vaccination through the case group created based on the preliminary study on the prevalence of seasonal influenza and pneumococcal vaccination in the elderly over the age of 65 living in Ankara.

The study, which includes cross-sectional prevalence and retrospective case-control stages, is planned to be carried out with individuals over the age of 65 living in Ankara province between November 1 and December 31, 2022.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Influenza Vaccination Among the Elderly Individuals

NCT02362919

Influenza

COMPLETED

Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong

NCT02957890

Influenza, Human

ACTIVE_NOT_RECRUITING PHASE4

Systems Investigation of Vaccine Responses in Aging and Frailty

NCT05291676

Influenza

RECRUITING PHASE2

The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine

NCT02269852

Influenza

COMPLETED PHASE4

Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older

NCT02665871

Influenza

UNKNOWN PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The elderly population and individuals with chronic diseases are at high risk for influenza and influenza-related pneumonia, and it is emphasized that taking pneumonia and influenza vaccine together is effective in reducing mortality as well as hospitalization rates and costs due to pneumonia, influenza, and congestive heart disease.

In recent years, progress has been made in vaccination as a result of the increase in health-seeking behavior due to the pandemic, the greater importance of influenza and pneumococcal vaccine application recommendations, and the perception of the prevention of lung infections due to COVID-19.

However, the discussions on the need to predict vaccine demand and examine health behaviors, health education, and research on new methods of vaccination efficacy in reducing future epidemics continue to be relevant.

This study that will be carried out will enable to determine the population-based prevalence of the relevant vaccines in the elderly and to determine the determinants of vaccination with the case group to be determined based on this.

Research questions-Prevalence

1. What is the prevalence of influenza vaccination in the elderly?
2. What is the prevalence of pneumonia vaccination in the elderly?

Research Questions - Case Control

1. Are socio-economic characteristics (region of residence, monthly income, education, perceived economic status) effective in vaccinating the elderly?
2. Are health-related features (chronic illness, drug use, previous vaccination status, priority preference in health care, frequency of hospitalization and hospitalization in the last six months, distance from health institution, self-defense behavior) effective in vaccinating the elderly?
3. Is the vaccination attitude effective in vaccinating the elderly?

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Immunization; Infection Influenza Pneumonia Vaccine Refusal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

-Over the age of 65.

Exclusion Criteria

* Cancer diagnosis
* Having a disease that will require immunosuppressive treatment
* Transplantation cases
* Rheumatoid arthritis
* Systemic lupus erythematosus
* Inflammatory bowel disease

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No